What is BLND's health score?

Blend Labs, Inc. (BLND) has a TradeApes health score of 50 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is BLND's estimated fair value?

Based on our 5-year discounted cash flow model, Blend Labs, Inc.'s estimated fair value is $0.96 per share, representing a -44.0% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is BLND undervalued or overvalued?

Our model currently rates BLND as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for BLND... Refresh in a moment for the full analysis.

Blend Labs, Inc. (BLND)

Technology Overvalued low mixed

$1.72

Updated: 2026-06-05

TradeApes Score

Financial Strength

50 Mixed

Operating Trend

73 Healthy

Relative Value

50 Mixed

Capital Allocation

10 Stressed

Risk

50 Mixed

Est. Fair Value $0.96

DCF Upside -44.0%

Sector Rank #4847 of 7441

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.